| 0 |
BACTERIAL NAIL INFECTION |
1 |
0.1429 |
| 1 |
LARYNGOCELE |
1 |
0.0667 |
| 2 |
MEDIASTINAL CYST |
1 |
0.0556 |
| 3 |
LICHEN NITIDUS |
1 |
0.0286 |
| 4 |
PRODUCT DIFFICULT TO REMOVE |
1 |
0.0167 |
| 5 |
CENTRAL AUDITORY PROCESSING DISORDER |
1 |
0.0167 |
| 6 |
HUMAN CHORIONIC GONADOTROPIN DECREASED |
1 |
0.0090 |
| 7 |
SOLAR URTICARIA |
1 |
0.0079 |
| 8 |
COLOBOMA |
1 |
0.0053 |
| 9 |
PROCEDURAL HYPERTENSION |
1 |
0.0053 |
| 10 |
THYMUS DISORDER |
1 |
0.0052 |
| 11 |
CHRONIC PIGMENTED PURPURA |
1 |
0.0051 |
| 12 |
OCULAR ROSACEA |
1 |
0.0049 |
| 13 |
LEPROSY |
1 |
0.0048 |
| 14 |
SUBSTANCE DEPENDENCE |
3 |
0.0045 |
| 15 |
POST INFLAMMATORY PIGMENTATION CHANGE |
2 |
0.0044 |
| 16 |
VESTIBULAR MIGRAINE |
1 |
0.0041 |
| 17 |
KELOID SCAR |
2 |
0.0039 |
| 18 |
STEROID THERAPY |
1 |
0.0035 |
| 19 |
CUBITAL TUNNEL SYNDROME |
1 |
0.0029 |
| 20 |
KIDNEY MALFORMATION |
1 |
0.0028 |
| 21 |
IMMUNE-MEDIATED CHOLANGITIS |
1 |
0.0028 |
| 22 |
CHRONIC LEFT VENTRICULAR FAILURE |
1 |
0.0028 |
| 23 |
INTESTINAL METASTASIS |
1 |
0.0028 |
| 24 |
HER2 POSITIVE BREAST CANCER |
1 |
0.0027 |
| 25 |
MEDIASTINAL MASS |
1 |
0.0026 |
| 26 |
LUNG DIFFUSION TEST DECREASED |
1 |
0.0025 |
| 27 |
TUMOUR ASSOCIATED FEVER |
1 |
0.0024 |
| 28 |
LICHENIFICATION |
1 |
0.0024 |
| 29 |
PERIOSTITIS |
1 |
0.0023 |
| 30 |
DIVORCED |
1 |
0.0023 |
| 31 |
REFLUX LARYNGITIS |
1 |
0.0023 |
| 32 |
IMPLANT SITE HAEMORRHAGE |
1 |
0.0023 |
| 33 |
SKIN INDENTATION |
1 |
0.0021 |
| 34 |
NAIL RIDGING |
1 |
0.0019 |
| 35 |
TOBACCO ABUSE |
1 |
0.0019 |
| 36 |
MARITAL PROBLEM |
1 |
0.0019 |
| 37 |
HEPATITIS C VIRUS |
1 |
0.0018 |
| 38 |
RENAL TUBULAR DYSFUNCTION |
1 |
0.0018 |
| 39 |
PERFUME SENSITIVITY |
1 |
0.0018 |
| 40 |
NAIL PSORIASIS |
1 |
0.0016 |
| 41 |
VITAMIN D INCREASED |
1 |
0.0016 |
| 42 |
INGROWN HAIR |
1 |
0.0014 |
| 43 |
CONGENITAL HYDRONEPHROSIS |
1 |
0.0014 |
| 44 |
PALMOPLANTAR KERATODERMA |
1 |
0.0014 |
| 45 |
GUTTATE PSORIASIS |
1 |
0.0012 |
| 46 |
COVID-19 IMMUNISATION |
1 |
0.0012 |
| 47 |
HEPATITIS A |
1 |
0.0012 |
| 48 |
MYCOTIC ALLERGY |
1 |
0.0012 |
| 49 |
ARTERIOVENOUS MALFORMATION |
1 |
0.0011 |
| 50 |
PYELOCALIECTASIS |
1 |
0.0010 |
| 51 |
PSYCHOTIC BEHAVIOUR |
1 |
0.0010 |
| 52 |
PRODUCT COATING ISSUE |
1 |
0.0010 |
| 53 |
DERMATITIS PSORIASIFORM |
2 |
0.0010 |
| 54 |
BLADDER DYSFUNCTION |
1 |
0.0010 |
| 55 |
INTERVERTEBRAL DISC COMPRESSION |
1 |
0.0010 |
| 56 |
URETEROLITHIASIS |
1 |
0.0010 |
| 57 |
ALLERGY TO ANIMAL |
1 |
0.0009 |
| 58 |
BLADDER DILATATION |
1 |
0.0009 |
| 59 |
LICHEN PLANUS |
2 |
0.0009 |
| 60 |
PAROTITIS |
1 |
0.0009 |
| 61 |
RENAL TUBULAR INJURY |
1 |
0.0008 |
| 62 |
STAPHYLOCOCCAL SKIN INFECTION |
1 |
0.0008 |
| 63 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 64 |
APPLICATION SITE EROSION |
1 |
0.0008 |
| 65 |
ANAEMIA POSTOPERATIVE |
1 |
0.0008 |
| 66 |
APPLICATION SITE INFLAMMATION |
1 |
0.0007 |
| 67 |
SKIN HYPERTROPHY |
2 |
0.0007 |
| 68 |
JOINT LOCK |
2 |
0.0007 |
| 69 |
POST HERPETIC NEURALGIA |
1 |
0.0007 |
| 70 |
JUDGEMENT IMPAIRED |
1 |
0.0007 |
| 71 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 72 |
CHEST X-RAY ABNORMAL |
2 |
0.0007 |
| 73 |
OSTEOMALACIA |
1 |
0.0006 |
| 74 |
COLONIC POLYP |
1 |
0.0006 |
| 75 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 76 |
PLANTAR FASCIITIS |
2 |
0.0006 |
| 77 |
SERUM FERRITIN DECREASED |
1 |
0.0006 |
| 78 |
SPINAL CORD INJURY |
1 |
0.0006 |
| 79 |
ROTATOR CUFF REPAIR |
1 |
0.0006 |
| 80 |
SKIN HYPOPIGMENTATION |
1 |
0.0006 |
| 81 |
BEHAVIOUR DISORDER |
3 |
0.0006 |
| 82 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 83 |
IMPULSIVE BEHAVIOUR |
2 |
0.0005 |
| 84 |
INFECTED SKIN ULCER |
1 |
0.0005 |
| 85 |
GINGIVAL RECESSION |
1 |
0.0005 |
| 86 |
HEPATIC MASS |
1 |
0.0005 |
| 87 |
SKIN PAPILLOMA |
2 |
0.0005 |
| 88 |
CHOLANGITIS SCLEROSING |
1 |
0.0005 |
| 89 |
PRE-EXISTING CONDITION IMPROVED |
3 |
0.0005 |
| 90 |
POST PROCEDURAL DISCOMFORT |
1 |
0.0005 |
| 91 |
EAR SWELLING |
1 |
0.0005 |
| 92 |
LANGUAGE DISORDER |
1 |
0.0005 |
| 93 |
HERPES SIMPLEX |
3 |
0.0005 |
| 94 |
TONGUE DISCOLOURATION |
2 |
0.0005 |
| 95 |
CORNEAL DISORDER |
1 |
0.0005 |
| 96 |
ONYCHOMYCOSIS |
2 |
0.0005 |
| 97 |
RHINITIS ALLERGIC |
2 |
0.0004 |
| 98 |
BREAKTHROUGH PAIN |
1 |
0.0004 |
| 99 |
IMPLANT SITE INFECTION |
1 |
0.0004 |
| 100 |
VITILIGO |
1 |
0.0004 |
| 101 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 102 |
RASH VESICULAR |
2 |
0.0004 |
| 103 |
DERMAL CYST |
1 |
0.0004 |
| 104 |
BREATH SOUNDS ABNORMAL |
2 |
0.0004 |
| 105 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 106 |
EXCORIATION |
1 |
0.0004 |
| 107 |
LIPOMA |
1 |
0.0004 |
| 108 |
SUBSTANCE ABUSE |
3 |
0.0004 |
| 109 |
SKIN WRINKLING |
1 |
0.0004 |
| 110 |
CLUMSINESS |
1 |
0.0004 |
| 111 |
SKIN INFECTION |
4 |
0.0004 |
| 112 |
VITAMIN B12 DECREASED |
1 |
0.0003 |
| 113 |
SPINAL OSTEOARTHRITIS |
3 |
0.0003 |
| 114 |
SKIN HAEMORRHAGE |
5 |
0.0003 |
| 115 |
CEREBROVASCULAR DISORDER |
1 |
0.0003 |
| 116 |
REBOUND ACID HYPERSECRETION |
1 |
0.0003 |
| 117 |
IRITIS |
1 |
0.0003 |
| 118 |
DERMATITIS ACNEIFORM |
2 |
0.0003 |
| 119 |
DUODENITIS |
1 |
0.0003 |
| 120 |
FIBROSIS |
1 |
0.0003 |
| 121 |
PIGMENTATION DISORDER |
2 |
0.0003 |
| 122 |
NIGHT SWEATS |
10 |
0.0003 |
| 123 |
SKIN FISSURES |
6 |
0.0003 |
| 124 |
PSORIATIC ARTHROPATHY |
12 |
0.0003 |
| 125 |
ECCHYMOSIS |
2 |
0.0003 |
| 126 |
WOUND COMPLICATION |
1 |
0.0003 |
| 127 |
CARPAL TUNNEL SYNDROME |
4 |
0.0003 |
| 128 |
HAND FRACTURE |
2 |
0.0003 |
| 129 |
SKIN WEEPING |
1 |
0.0003 |
| 130 |
SPONDYLITIS |
1 |
0.0003 |
| 131 |
RASH PUSTULAR |
2 |
0.0003 |
| 132 |
DEVICE KINK |
1 |
0.0003 |
| 133 |
MOUTH HAEMORRHAGE |
2 |
0.0003 |
| 134 |
ALCOHOL USE |
1 |
0.0003 |
| 135 |
WOUND HAEMORRHAGE |
1 |
0.0003 |
| 136 |
NEURODERMATITIS |
1 |
0.0003 |
| 137 |
SNORING |
1 |
0.0003 |
| 138 |
THERAPEUTIC PRODUCT INEFFECTIVE |
1 |
0.0003 |
| 139 |
SENSATION OF HEAVINESS |
1 |
0.0003 |
| 140 |
PROSTATOMEGALY |
1 |
0.0003 |
| 141 |
HYPERLIPIDAEMIA |
3 |
0.0003 |
| 142 |
FOREIGN BODY |
1 |
0.0002 |
| 143 |
TRIGEMINAL NEURALGIA |
1 |
0.0002 |
| 144 |
TRIGGER FINGER |
1 |
0.0002 |
| 145 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 146 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 147 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 148 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 149 |
PARONYCHIA |
1 |
0.0002 |
| 150 |
PRODUCT ADHESION ISSUE |
8 |
0.0002 |
| 151 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 152 |
SLEEP APNOEA SYNDROME |
4 |
0.0002 |
| 153 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 154 |
VITAMIN D DEFICIENCY |
2 |
0.0002 |
| 155 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 156 |
HOSPICE CARE |
2 |
0.0002 |
| 157 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 158 |
ECONOMIC PROBLEM |
3 |
0.0002 |
| 159 |
OSTEOPENIA |
3 |
0.0002 |
| 160 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 161 |
DRY THROAT |
2 |
0.0002 |
| 162 |
AMMONIA INCREASED |
1 |
0.0002 |
| 163 |
PHLEBITIS |
1 |
0.0002 |
| 164 |
FOOD CRAVING |
1 |
0.0002 |
| 165 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 166 |
CHEILITIS |
1 |
0.0002 |
| 167 |
OESOPHAGITIS |
2 |
0.0002 |
| 168 |
SKIN LESION |
5 |
0.0002 |
| 169 |
APPLICATION SITE PAIN |
4 |
0.0002 |
| 170 |
HYPERKERATOSIS |
1 |
0.0002 |
| 171 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 172 |
SKIN TOXICITY |
1 |
0.0002 |
| 173 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
3 |
0.0002 |
| 174 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 175 |
SKIN ATROPHY |
1 |
0.0002 |
| 176 |
METASTASES TO LUNG |
2 |
0.0002 |
| 177 |
SKIN WARM |
1 |
0.0002 |
| 178 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 179 |
CATARACT OPERATION |
1 |
0.0002 |
| 180 |
SINUS HEADACHE |
1 |
0.0002 |
| 181 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 182 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 183 |
SWELLING OF EYELID |
1 |
0.0002 |
| 184 |
MULTIPLE INJURIES |
1 |
0.0002 |
| 185 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 186 |
HIATUS HERNIA |
2 |
0.0002 |
| 187 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 188 |
POLYP |
1 |
0.0002 |
| 189 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 190 |
EAR INFECTION |
4 |
0.0002 |
| 191 |
MALIGNANT MELANOMA |
2 |
0.0001 |
| 192 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 193 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 194 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 195 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
1 |
0.0001 |
| 196 |
CORONARY ARTERY OCCLUSION |
2 |
0.0001 |
| 197 |
JOINT EFFUSION |
1 |
0.0001 |
| 198 |
DERMATITIS |
3 |
0.0001 |
| 199 |
PAPULE |
1 |
0.0001 |
| 200 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 201 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 202 |
THERMAL BURN |
1 |
0.0001 |
| 203 |
UTERINE LEIOMYOMA |
1 |
0.0001 |
| 204 |
SENSITIVE SKIN |
1 |
0.0001 |
| 205 |
BONE LOSS |
2 |
0.0001 |
| 206 |
DERMATITIS ATOPIC |
7 |
0.0001 |
| 207 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 208 |
EPILEPSY |
4 |
0.0001 |
| 209 |
LYMPHOMA |
2 |
0.0001 |
| 210 |
TENDONITIS |
2 |
0.0001 |
| 211 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 212 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 213 |
RENAL CYST |
1 |
0.0001 |
| 214 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 215 |
PSORIASIS |
16 |
0.0001 |
| 216 |
HYPERAESTHESIA |
1 |
0.0001 |
| 217 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 218 |
LIP SWELLING |
4 |
0.0001 |
| 219 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 220 |
SKIN PLAQUE |
1 |
0.0001 |
| 221 |
CHRONIC KIDNEY DISEASE |
9 |
0.0001 |
| 222 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 223 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 224 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 225 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 226 |
ECZEMA |
6 |
0.0001 |
| 227 |
APPLICATION SITE ERYTHEMA |
3 |
0.0001 |
| 228 |
NAIL DISORDER |
1 |
0.0001 |
| 229 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 230 |
DRUG ERUPTION |
2 |
0.0001 |
| 231 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 232 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 233 |
LIP DRY |
1 |
0.0001 |
| 234 |
END STAGE RENAL DISEASE |
2 |
0.0001 |
| 235 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 236 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 237 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 238 |
SWELLING FACE |
7 |
0.0001 |
| 239 |
HEPATIC STEATOSIS |
2 |
0.0001 |
| 240 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 241 |
TUBULOINTERSTITIAL NEPHRITIS |
2 |
0.0001 |
| 242 |
SKIN EXFOLIATION |
9 |
0.0001 |
| 243 |
LACERATION |
1 |
0.0001 |
| 244 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 245 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 246 |
GASTRIC ULCER |
2 |
0.0001 |
| 247 |
ATELECTASIS |
1 |
0.0001 |
| 248 |
ERUCTATION |
2 |
0.0001 |
| 249 |
EAR PAIN |
2 |
0.0001 |
| 250 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 251 |
HEPATOMEGALY |
1 |
0.0001 |
| 252 |
KNEE OPERATION |
1 |
0.0001 |
| 253 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 254 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
2 |
0.0001 |
| 255 |
EMPHYSEMA |
1 |
0.0001 |
| 256 |
CORONARY ARTERY DISEASE |
3 |
0.0001 |
| 257 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 258 |
BONE DENSITY DECREASED |
3 |
0.0001 |
| 259 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 260 |
SCRATCH |
1 |
0.0001 |
| 261 |
JOINT DISLOCATION |
1 |
0.0001 |
| 262 |
OSTEOARTHRITIS |
4 |
0.0001 |
| 263 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 264 |
SKIN LACERATION |
1 |
0.0001 |
| 265 |
MENTAL DISORDER |
4 |
0.0001 |
| 266 |
WOUND INFECTION |
1 |
0.0001 |
| 267 |
FUNGAL INFECTION |
3 |
0.0001 |
| 268 |
DRY SKIN |
12 |
0.0001 |
| 269 |
EYE INFECTION |
1 |
0.0001 |
| 270 |
REBOUND EFFECT |
1 |
0.0001 |
| 271 |
MICTURITION URGENCY |
1 |
0.0001 |
| 272 |
CAESAREAN SECTION |
1 |
0.0001 |
| 273 |
SPLENOMEGALY |
1 |
0.0001 |
| 274 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 275 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 276 |
BACTERAEMIA |
1 |
0.0001 |
| 277 |
ACCIDENT |
1 |
0.0001 |
| 278 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 279 |
LOCALISED INFECTION |
2 |
0.0001 |
| 280 |
NOCTURIA |
1 |
0.0001 |
| 281 |
PANIC ATTACK |
3 |
0.0001 |
| 282 |
FIBROMYALGIA |
2 |
0.0001 |
| 283 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 284 |
PRURITUS |
31 |
0.0001 |
| 285 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 286 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 287 |
DEVICE DEPLOYMENT ISSUE |
1 |
0.0001 |
| 288 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 289 |
INFLAMMATION |
4 |
0.0001 |
| 290 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
4 |
0.0001 |
| 291 |
ANHEDONIA |
2 |
0.0001 |
| 292 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 293 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 294 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 295 |
UVEITIS |
1 |
0.0001 |
| 296 |
PALLOR |
2 |
0.0001 |
| 297 |
OSTEOPOROSIS |
3 |
0.0001 |
| 298 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 299 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 300 |
MASS |
1 |
0.0001 |
| 301 |
WOUND |
2 |
0.0001 |
| 302 |
BLISTER |
4 |
0.0001 |
| 303 |
SLEEP DISORDER |
5 |
0.0001 |
| 304 |
LYMPHOPENIA |
1 |
0.0001 |
| 305 |
SKIN BURNING SENSATION |
5 |
0.0001 |
| 306 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 307 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 308 |
HYPOKINESIA |
1 |
0.0001 |
| 309 |
PULMONARY MASS |
1 |
0.0001 |
| 310 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
0.0001 |
| 311 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 312 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 313 |
DISCOMFORT |
4 |
0.0001 |
| 314 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 315 |
FEELING HOT |
4 |
0.0001 |
| 316 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 317 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 318 |
PARAESTHESIA |
10 |
0.0001 |
| 319 |
HEAD INJURY |
2 |
0.0001 |
| 320 |
PNEUMOTHORAX |
1 |
0.0001 |
| 321 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 322 |
CYSTITIS |
2 |
0.0001 |
| 323 |
OBESITY |
1 |
0.0001 |
| 324 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 325 |
DEPRESSION |
14 |
0.0001 |
| 326 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 327 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 328 |
DRY EYE |
3 |
0.0001 |
| 329 |
VIRAL INFECTION |
2 |
0.0001 |
| 330 |
LEUKOPENIA |
3 |
0.0001 |
| 331 |
SKIN DISORDER |
2 |
0.0001 |
| 332 |
CELLULITIS |
3 |
0.0001 |
| 333 |
GASTRIC DISORDER |
2 |
0.0001 |
| 334 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 335 |
RASH MACULAR |
2 |
0.0001 |
| 336 |
GOUT |
1 |
0.0001 |
| 337 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 338 |
CRYING |
2 |
0.0001 |
| 339 |
HAEMATOCHEZIA |
3 |
0.0001 |
| 340 |
BRONCHITIS |
4 |
0.0001 |
| 341 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 342 |
URTICARIA |
9 |
0.0001 |
| 343 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 344 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 345 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 346 |
FRACTURE |
1 |
0.0001 |
| 347 |
FOOT FRACTURE |
1 |
0.0001 |
| 348 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 349 |
NEUROPATHY PERIPHERAL |
5 |
0.0001 |
| 350 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 351 |
INCREASED APPETITE |
1 |
0.0001 |
| 352 |
HERPES ZOSTER |
3 |
0.0001 |
| 353 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 354 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 355 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 356 |
GLAUCOMA |
1 |
0.0001 |
| 357 |
HERNIA |
1 |
0.0001 |
| 358 |
HAEMORRHOIDS |
1 |
0.0001 |
| 359 |
ORAL HERPES |
1 |
0.0001 |
| 360 |
SURGERY |
3 |
0.0001 |
| 361 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 362 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 363 |
PREGNANCY |
1 |
0.0000 |
| 364 |
THROMBOSIS |
4 |
0.0000 |
| 365 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 366 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 367 |
THERAPEUTIC RESPONSE DECREASED |
3 |
0.0000 |
| 368 |
PLEURAL EFFUSION |
3 |
0.0000 |
| 369 |
VERTIGO |
3 |
0.0000 |
| 370 |
NASOPHARYNGITIS |
9 |
0.0000 |
| 371 |
SINUSITIS |
5 |
0.0000 |
| 372 |
HAEMOGLOBIN DECREASED |
5 |
0.0000 |
| 373 |
RIB FRACTURE |
1 |
0.0000 |
| 374 |
DRUG DOSE OMISSION |
8 |
0.0000 |
| 375 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 376 |
PAIN IN EXTREMITY |
14 |
0.0000 |
| 377 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 378 |
EATING DISORDER |
1 |
0.0000 |
| 379 |
URINARY TRACT INFECTION |
8 |
0.0000 |
| 380 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 381 |
SKIN CANCER |
1 |
0.0000 |
| 382 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 383 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 384 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 385 |
INFLUENZA |
5 |
0.0000 |
| 386 |
INJECTION SITE PRURITUS |
3 |
0.0000 |
| 387 |
SNEEZING |
1 |
0.0000 |
| 388 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 389 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 390 |
SUICIDAL IDEATION |
4 |
0.0000 |
| 391 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 392 |
INJECTION SITE REACTION |
3 |
0.0000 |
| 393 |
RASH |
19 |
0.0000 |
| 394 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 395 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 396 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 397 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 398 |
PALPITATIONS |
5 |
0.0000 |
| 399 |
ANXIETY |
12 |
0.0000 |
| 400 |
PRESYNCOPE |
1 |
0.0000 |
| 401 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 402 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 403 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 404 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 405 |
AGGRESSION |
2 |
0.0000 |
| 406 |
COVID-19 |
7 |
0.0000 |
| 407 |
HOT FLUSH |
3 |
0.0000 |
| 408 |
GASTRIC CANCER |
1 |
0.0000 |
| 409 |
FLUSHING |
4 |
0.0000 |
| 410 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 411 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 412 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 413 |
SKIN ULCER |
1 |
0.0000 |
| 414 |
RASH GENERALISED |
1 |
0.0000 |
| 415 |
DIPLOPIA |
1 |
0.0000 |
| 416 |
DEAFNESS |
1 |
0.0000 |
| 417 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 418 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 419 |
DEPRESSED MOOD |
2 |
0.0000 |
| 420 |
HYPERSENSITIVITY |
7 |
0.0000 |
| 421 |
RENAL FAILURE |
5 |
0.0000 |
| 422 |
INSOMNIA |
10 |
0.0000 |
| 423 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 424 |
PAIN OF SKIN |
1 |
0.0000 |
| 425 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 426 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 427 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 428 |
PRODUCT QUALITY ISSUE |
5 |
0.0000 |
| 429 |
MOOD ALTERED |
1 |
0.0000 |
| 430 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 431 |
PRODUCT USE IN UNAPPROVED INDICATION |
9 |
0.0000 |
| 432 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 433 |
FEELING COLD |
1 |
0.0000 |
| 434 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 435 |
ALOPECIA |
7 |
0.0000 |
| 436 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 437 |
ASTHMA |
4 |
0.0000 |
| 438 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 439 |
PAIN IN JAW |
1 |
0.0000 |
| 440 |
ANGINA PECTORIS |
1 |
0.0000 |
| 441 |
BALANCE DISORDER |
3 |
0.0000 |
| 442 |
BACK PAIN |
8 |
0.0000 |
| 443 |
DRUG WITHDRAWAL SYNDROME |
3 |
0.0000 |
| 444 |
NASAL CONGESTION |
2 |
0.0000 |
| 445 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 446 |
RENAL INJURY |
1 |
0.0000 |
| 447 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 448 |
HYPOAESTHESIA |
5 |
0.0000 |
| 449 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 450 |
APHASIA |
1 |
0.0000 |
| 451 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 452 |
INJECTION SITE RASH |
1 |
0.0000 |
| 453 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 454 |
SWELLING |
3 |
0.0000 |
| 455 |
HEADACHE |
20 |
0.0000 |
| 456 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 457 |
DYSPHAGIA |
3 |
0.0000 |
| 458 |
CONTUSION |
3 |
0.0000 |
| 459 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 460 |
HYPERHIDROSIS |
4 |
0.0000 |
| 461 |
PRODUCT DOSE OMISSION |
2 |
0.0000 |
| 462 |
OSTEONECROSIS |
1 |
0.0000 |
| 463 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 464 |
HEART RATE INCREASED |
3 |
0.0000 |
| 465 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 466 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 467 |
SYNCOPE |
3 |
0.0000 |
| 468 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 469 |
EYE PRURITUS |
1 |
0.0000 |
| 470 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 471 |
PAIN |
18 |
0.0000 |
| 472 |
HAEMATURIA |
1 |
0.0000 |
| 473 |
ERYTHEMA |
6 |
0.0000 |
| 474 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 475 |
HYPOXIA |
1 |
0.0000 |
| 476 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 477 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 478 |
MOBILITY DECREASED |
2 |
0.0000 |
| 479 |
INFECTION |
4 |
0.0000 |
| 480 |
AGITATION |
2 |
0.0000 |
| 481 |
DYSURIA |
1 |
0.0000 |
| 482 |
CHEST PAIN |
5 |
0.0000 |
| 483 |
DIABETES MELLITUS |
2 |
0.0000 |
| 484 |
ANAEMIA |
5 |
0.0000 |
| 485 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 486 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 487 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 488 |
CHILLS |
3 |
0.0000 |
| 489 |
NAUSEA |
20 |
0.0000 |
| 490 |
DIARRHOEA |
16 |
0.0000 |
| 491 |
EMOTIONAL DISTRESS |
3 |
0.0000 |
| 492 |
DYSPNOEA |
14 |
0.0000 |
| 493 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 494 |
TREATMENT FAILURE |
2 |
0.0000 |
| 495 |
TREMOR |
4 |
0.0000 |
| 496 |
DIZZINESS |
12 |
0.0000 |
| 497 |
FALL |
8 |
0.0000 |
| 498 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 499 |
PRODUCT DOSE OMISSION ISSUE |
7 |
0.0000 |
| 500 |
HYPERTENSION |
5 |
0.0000 |
| 501 |
HYPOACUSIS |
1 |
0.0000 |
| 502 |
FATIGUE |
18 |
0.0000 |
| 503 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 504 |
CONSTIPATION |
5 |
0.0000 |
| 505 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 506 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 507 |
DRUG INEFFECTIVE |
30 |
0.0000 |
| 508 |
TACHYCARDIA |
2 |
0.0000 |
| 509 |
WEIGHT INCREASED |
5 |
0.0000 |
| 510 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 511 |
THROAT IRRITATION |
1 |
0.0000 |
| 512 |
NEUTROPENIA |
3 |
0.0000 |
| 513 |
VISION BLURRED |
3 |
0.0000 |
| 514 |
SKIN IRRITATION |
1 |
0.0000 |
| 515 |
TINNITUS |
1 |
0.0000 |
| 516 |
HYPOKALAEMIA |
1 |
0.0000 |
| 517 |
ARTHRALGIA |
9 |
0.0000 |
| 518 |
RENAL DISORDER |
1 |
0.0000 |
| 519 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 520 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 521 |
ASTHENIA |
8 |
0.0000 |
| 522 |
VOMITING |
10 |
0.0000 |
| 523 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 524 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 525 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 526 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 527 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 528 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 529 |
LUNG DISORDER |
1 |
0.0000 |
| 530 |
CONDITION AGGRAVATED |
6 |
0.0000 |
| 531 |
FLUID RETENTION |
1 |
0.0000 |
| 532 |
INJECTION SITE PAIN |
6 |
0.0000 |
| 533 |
NERVOUSNESS |
1 |
0.0000 |
| 534 |
PANCREATITIS |
1 |
0.0000 |
| 535 |
DRUG INTERACTION |
3 |
0.0000 |
| 536 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 537 |
DRUG DEPENDENCE |
3 |
0.0000 |
| 538 |
PNEUMONIA |
6 |
0.0000 |
| 539 |
OEDEMA |
1 |
0.0000 |
| 540 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 541 |
ARTHROPATHY |
1 |
0.0000 |
| 542 |
WEIGHT DECREASED |
5 |
0.0000 |
| 543 |
NECK PAIN |
1 |
0.0000 |
| 544 |
COUGH |
5 |
0.0000 |
| 545 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 546 |
EYE PAIN |
1 |
0.0000 |
| 547 |
INCORRECT DOSE ADMINISTERED |
4 |
0.0000 |
| 548 |
LETHARGY |
1 |
0.0000 |
| 549 |
EYE IRRITATION |
1 |
0.0000 |
| 550 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 551 |
PYREXIA |
6 |
0.0000 |
| 552 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 553 |
DYSPHONIA |
1 |
0.0000 |
| 554 |
BLADDER CANCER |
1 |
0.0000 |
| 555 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 556 |
WHEEZING |
1 |
0.0000 |
| 557 |
CATARACT |
1 |
0.0000 |
| 558 |
IRRITABILITY |
1 |
0.0000 |
| 559 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 560 |
STOMATITIS |
1 |
0.0000 |
| 561 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 562 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 563 |
MALAISE |
7 |
0.0000 |
| 564 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 565 |
RHINORRHOEA |
1 |
0.0000 |
| 566 |
DEVICE EXPULSION |
1 |
0.0000 |
| 567 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 568 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 569 |
DEHYDRATION |
2 |
0.0000 |
| 570 |
OFF LABEL USE |
13 |
0.0000 |
| 571 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 572 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 573 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 574 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 575 |
EPISTAXIS |
1 |
0.0000 |
| 576 |
HALLUCINATION |
1 |
0.0000 |
| 577 |
ACNE |
1 |
0.0000 |
| 578 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 579 |
HOSPITALISATION |
2 |
0.0000 |
| 580 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 581 |
DECREASED APPETITE |
3 |
0.0000 |
| 582 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 583 |
ARTHRITIS |
1 |
0.0000 |
| 584 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 585 |
CARDIAC FAILURE |
1 |
0.0000 |
| 586 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 587 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 588 |
DRUG ABUSE |
1 |
0.0000 |
| 589 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 590 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 591 |
MYALGIA |
2 |
0.0000 |
| 592 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 593 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 594 |
MUSCLE SPASMS |
2 |
0.0000 |
| 595 |
CARDIAC DISORDER |
1 |
0.0000 |
| 596 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 597 |
ILLNESS |
1 |
0.0000 |
| 598 |
HAEMORRHAGE |
1 |
0.0000 |
| 599 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 600 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 601 |
SEIZURE |
1 |
0.0000 |
| 602 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 603 |
JOINT SWELLING |
1 |
0.0000 |
| 604 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 605 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 606 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 607 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 608 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 609 |
SOMNOLENCE |
1 |
0.0000 |
| 610 |
FEELING ABNORMAL |
1 |
0.0000 |
| 611 |
DEATH |
2 |
0.0000 |